APA (7th ed.) Citation

Salaga, M., Mokrowiecka, A., Zielinska, M., Malecka-Panas, E., Kordek, R., Kamysz, E., & Fichna, J. (2017). New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration. The Journal of pharmacology and experimental therapeutics, 363(1), 92-103. https://doi.org/10.1124/jpet.117.242586

Chicago Style (17th ed.) Citation

Salaga, Maciej, Anna Mokrowiecka, Marta Zielinska, Ewa Malecka-Panas, Radzislaw Kordek, Elzbieta Kamysz, and Jakub Fichna. "New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice After Topical Administration." The Journal of Pharmacology and Experimental Therapeutics 363, no. 1 (2017): 92-103. https://doi.org/10.1124/jpet.117.242586.

MLA (9th ed.) Citation

Salaga, Maciej, et al. "New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice After Topical Administration." The Journal of Pharmacology and Experimental Therapeutics, vol. 363, no. 1, 2017, pp. 92-103, https://doi.org/10.1124/jpet.117.242586.